Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study

Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study

Abstract Background Polycystic ovarian syndrome (PCOS) is a highly variable syndrome and one of the most common female endocrine disorders. Although the association inositols-glucomannan may represent a good therapeutic strategy in the treatment of PCOS women with insulin resistance, the effect of i...

Full description

Bibliographic Details
Main Authors: Jacopo Troisi, Claudia Cinque, Luigi Giugliano, Steven Symes, Sean Richards, David Adair, Pierpaolo Cavallo, Laura Sarno, Giovanni Scala, Maria Caiazza, Maurizio Guida
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Journal of Ovarian Research
Subjects:
Polycystic ovary syndrome
Inositols-glucomannan association
Metabolomics
Online Access:http://link.springer.com/article/10.1186/s13048-019-0500-x

Internet

http://link.springer.com/article/10.1186/s13048-019-0500-x

Similar Items